Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
20058.5k citationsHude Quan, Vijaya Sundararajan et al.Medical Careprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Thomas E. Feasby
Since
Specialization
Citations
This map shows the geographic impact of Thomas E. Feasby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Feasby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Feasby more than expected).
Fields of papers citing papers by Thomas E. Feasby
This network shows the impact of papers produced by Thomas E. Feasby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Feasby. The network helps show where Thomas E. Feasby may publish in the future.
Co-authorship network of co-authors of Thomas E. Feasby
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Feasby.
A scholar is included among the top collaborators of Thomas E. Feasby based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Thomas E. Feasby. Thomas E. Feasby is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Feasby, Thomas E., Hude Quan, Michelle Tubman, et al.. (2012). Appropriateness of the use of intravenous immune globulin before and after the introduction of a utilization control program.. PubMed. 6(1). e28–34.10 indexed citations
Findlay, J. Max, B. Elaine Marchak, David M. Pelz, & Thomas E. Feasby. (2004). Carotid Endarterectomy: A Review. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 31(1). 22–36.22 indexed citations
10.
Buchan, Alastair M. & Thomas E. Feasby. (2000). Treating stroke - Response. Canadian Medical Association Journal. 162(9). 1273–1274.1 indexed citations
11.
Hill, Michael D., et al.. (2000). Reactions to alteplase in patients with acute thrombotic stroke.. Canadian Medical Association Journal. 163(4). 388–389.2 indexed citations
12.
Buchan, Alastair M. & Thomas E. Feasby. (2000). Stroke thrombolysis: is tissue plasminogen activator a defibrillator for the brain?. PubMed. 162(1). 47–8.3 indexed citations
13.
Karbalai, Hasneen, et al.. (1999). Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation. Stroke. 30. 248–248.16 indexed citations
14.
Ghali, William A., et al.. (1998). The risks of inappropriate carotid endarterectomy. Annals of Neurology. 44. 510–510.2 indexed citations
Feasby, Thomas E.. (1992). Textbook of Clinical Neuropharmacology and Therapeutics.. Journal of Psychiatry and Neuroscience. 17(3). 128–128.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.